Clinical trial

The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes

NCT07564752

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

BIOLOGICAL · Unmapped registry intervention Blood test Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Urine sample Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The Effect of Improved Glycemic Control on the Composition and Function of High-Density Lipoproteins (HDL) in Patients With Type 1 Diabetes

Design: OBSERVATIONAL · Status: RECRUITING · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-02-25

PhaseN/A

Conditions

Type 1 Diabetesverified · MONDO: type 1 diabetes mellitus

Interventions

Blood testBIOLOGICAL

Urine sampleBIOLOGICAL

Sponsors & collaborators

Centre Hospitalier Universitaire Dijonlead sponsor

Mapped research locations

DijonFrance1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07564752 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.